Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China · Delayed Price · Currency is CNY 38.06
+0.04 (0.11%)
Sep 4, 2026, 3:00 PM CST
SHA:600211 Market Cap
SHA:600211 has a market cap or net worth of 12.12 billion as of September 4, 2026. Its market cap has decreased by -24.51% in one year.
Market Cap
12.12B
Enterprise Value
9.86B
Revenue
2.89B
Ranking
n/a
PE Ratio
12.46
Stock Price
38.06
ChartMarket Cap Chart
Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 12.12B, an increase of 736.66%. That is a compound annual growth rate of 8.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 12.12B | -11.66% |
| Dec 31, 2025 | 13.71B | 15.19% |
| Dec 31, 2024 | 11.91B | -1.59% |
| Dec 29, 2023 | 12.10B | 35.86% |
| Dec 30, 2022 | 8.91B | -31.40% |
| Dec 31, 2021 | 12.98B | -22.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Hisun Pharmaceutical | 13.48B |
| Zhejiang Jiuzhou Pharmaceutical | 13.16B |
| Shenzhen Hepalink Pharmaceutical Group | 13.06B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.74B |
| Guobang Pharma | 12.03B |
| Wedge Industrial | 12.02B |
| Zhejiang Medicine | 12.02B |
| Shanghai Shyndec Pharmaceutical | 11.39B |